Search results
Evolus reports first-ever adjusted profit in Q2 fueled by strong sales of Botox rival
Livemint· 14 hours agoThe company, which launched Jeuveau in 2019, has focused on expanding the reach of its cosmetic treatment, particularly targeting a younger demographic ...
Blake Lively Debuts Hair Care Range 'Blake Brown Beauty' That Ditches Conditioning
Times Now· 3 hours agoAfter marking her entrepreneurial journey with the launch of her non-alcoholic sparkling mixer in...
'Identify Creamy Layers Among SC/STs, Take Them Out Of...': Justice Gavai's Direction To State For...
News18· 4 hours agoJustice BR Gavai, while reading the concurring opinion during the Supreme Court ruling in the SC/ST...
Where to Buy Modalert Online in the UK | TOP-4 Modafinil Vendors
NDTV· 52 minutes agoSeveral seemingly great online pharmacies sell Modalert, a popular modafinil brand, but only a few of them are legit. It sheds light on everything you need to know about obtaining modafinil ...
Zydus secures marketing approval for cancer treatment product by Mexican regulatory authority -...
The Times of India· 1 day agoNEW DELHI: Zydus Lifesciences Ltd announced on Wednesday that Mamitra, a Trastuzumab biosimilar used...
How to Buy Modafinil Online in 2023? Discover Best Nootropic Vendors
NDTV· 16 hours agoIt also reveals the drug's legality in different countries, its benefits, and possible side effects,...
Shah Rukh Khan To Be Rushed For Eye Treatment In US? Here's What We Know
Mashable India· 2 days agoReports have claimed that Bollywood actor Shah Rukh Khan is set to fly to the US for an eye ...
Toll in Kerala landslides mounts to 162, 91 missing | Central India's Premier English Daily
Central Chronicle· 24 hours agoWayanad, July 31 (UNI) The death toll in landslides in Kerala’s Wayand district rose to 162 on Wednesday with 91 people still missing, officials said. A ...
RBI issues Master Direction on treatment of Wilful Defaulters and Large Defaulters
Business Standard India· 1 day agoThe RBI yesterday issued a Master Direction on the Treatment of Wilful Defaulters and Large Defaulters under which banks and NBFCs will have to examine the 'wilful default ...
Japan's Otsuka Pharma to pay up to $1.1 bln to acquire Jnana Therapeutics - ET HealthWorld | Pharma
The Economic Times· 2 hours agoTokyo: Japan's Otsuka Pharmaceutical said on Thursday it agreed to pay more than $1 billion to...